Tower Research Capital (TRC)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-100
| Closed | -$1K | – | 4811 |
|
|
2019
Q3 | $1K | Sell |
100
-343
| -77% | -$3.43K | ﹤0.01% | 4005 |
|
|
2019
Q2 | $3K | Sell |
443
-1,947
| -81% | -$13.2K | ﹤0.01% | 3211 |
|
|
2019
Q1 | $11K | Buy |
2,390
+2,285
| +2,176% | +$10.5K | ﹤0.01% | 2655 |
|
|
2018
Q4 | $0 | Sell |
105
-72
| -41% | – | ﹤0.01% | 4637 |
|
|
2018
Q3 | $1K | Buy |
+177
| New | +$1K | ﹤0.01% | 3673 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4399 |
|
|
2017
Q3 | – | Sell |
-252
| Closed | -$2K | – | 4430 |
|
|
2017
Q2 | $2K | Sell |
252
-3,602
| -93% | -$28.6K | ﹤0.01% | 2420 |
|
|
2017
Q1 | $36K | Buy |
3,854
+442
| +13% | +$4.13K | ﹤0.01% | 920 |
|
|
2016
Q4 | $29K | Buy |
3,412
+2,187
| +179% | +$18.6K | ﹤0.01% | 1823 |
|
|
2016
Q3 | $8K | Buy |
+1,225
| New | +$8K | ﹤0.01% | 2261 |
|
|
2016
Q2 | – | Sell |
-554
| Closed | -$2K | – | 5269 |
|
|
2016
Q1 | $2K | Sell |
554
-6,225
| -92% | -$22.5K | ﹤0.01% | 3514 |
|
|
2015
Q4 | $42K | Buy |
6,779
+6,179
| +1,030% | +$38.3K | 0.01% | 665 |
|
|
2015
Q3 | $3K | Sell |
600
-6,147
| -91% | -$30.7K | ﹤0.01% | 3210 |
|
|
2015
Q2 | $50K | Sell |
6,747
-4,391
| -39% | -$32.5K | ﹤0.01% | 1374 |
|
|
2015
Q1 | $66K | Buy |
11,138
+10,104
| +977% | +$59.9K | 0.01% | 1249 |
|
|
2014
Q4 | $8K | Buy |
+1,034
| New | +$8K | ﹤0.01% | 2382 |
|
|
2014
Q3 | – | Sell |
-2,041
| Closed | -$9K | – | 5113 |
|
|
2014
Q2 | $9K | Sell |
2,041
-1,093
| -35% | -$4.82K | ﹤0.01% | 2471 |
|
|
2014
Q1 | $13K | Buy |
+3,134
| New | +$13K | ﹤0.01% | 2376 |
|
|
2013
Q4 | – | Sell |
-5,687
| Closed | -$29K | – | 5089 |
|
|
2013
Q3 | $29K | Buy |
5,687
+5,487
| +2,744% | +$28K | ﹤0.01% | 2410 |
|
|
2013
Q2 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 3780 |
|